{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:46:03Z","timestamp":1791179163771,"version":"4.1.0"},"reference-count":95,"publisher":"Georg Thieme Verlag KG","issue":"04","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Respir Crit Care Med"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\n          Pseudomonas aeruginosa (PA) in patients with bronchiectasis (BE) is associated with a poor outcome and quality of life, and its presence is considered a marker of disease severity. This opportunistic pathogen is known for its ability to produce biofilms on biotic or abiotic surfaces and to survive environmental stress exerted by antimicrobials, inflammation, and nutrient or oxygen depletion. The presence of PA biofilms has been linked to chronic respiratory infection in cystic fibrosis but not in BE. There is considerable inconsistency in the reported infection\/eradication rates of PA and chronic PA. In addition, inadequate antimicrobial treatment may potentiate the progression from intermittent to chronic infection and also the emergence of antibiotic resistance. A better comprehension of the pathophysiology of PA infections and its implications for BE is urgently needed. This can drive improvements in diagnostic accuracy, can move us toward a new consensus definition of chronic infection, can better define the follow-up of patients at risk of PA, and can achieve more successful eradication rates. In addition, the new technological advances regarding molecular diagnostics, -omics, and biomarkers require us to reconsider our traditional concepts.<\/jats:p>","DOI":"10.1055\/s-0041-1730921","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T22:34:05Z","timestamp":1626302045000},"page":"587-594","source":"Crossref","is-referenced-by-count":14,"title":["Pseudomonas aeruginosa in Bronchiectasis"],"prefix":"10.1055","volume":"42","author":[{"given":"Laia","family":"Fern\u00e1ndez-Barat","sequence":"additional","affiliation":[{"name":"Cellex Laboratory, CibeRes (Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Respiratorias, 06\/06\/0028), Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain"},{"name":"School of Medicine, University of Barcelona, Barcelona, Spain"},{"name":"Department of Pneumology, Respiratory Institute, Hospital Clinic of Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Alcaraz-Serrano","sequence":"additional","affiliation":[{"name":"Cellex Laboratory, CibeRes (Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Respiratorias, 06\/06\/0028), Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain"},{"name":"School of Medicine, University of Barcelona, Barcelona, Spain"},{"name":"Department of Pneumology, Respiratory Institute, Hospital Clinic of Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanel","family":"Amaro","sequence":"additional","affiliation":[{"name":"Cellex Laboratory, CibeRes (Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Respiratorias, 06\/06\/0028), Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain"},{"name":"School of Medicine, University of Barcelona, Barcelona, Spain"},{"name":"Department of Pneumology, Respiratory Institute, Hospital Clinic of Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Torres","sequence":"additional","affiliation":[{"name":"Cellex Laboratory, CibeRes (Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Respiratorias, 06\/06\/0028), Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain"},{"name":"School of Medicine, University of Barcelona, Barcelona, Spain"},{"name":"Department of Pneumology, Respiratory Institute, Hospital Clinic of Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2021,7,14]]},"reference":[{"issue":"06","key":"ref1","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1164\/rccm.201303-0411CI","article-title":"Non-cystic fibrosis bronchiectasis","volume":"188","author":"P J McShane","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"ref2","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1513\/AnnalsATS.201507-472OC","article-title":"Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity","volume":"12","author":"S Lonni","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"11","key":"ref3","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1473-3099(02)00437-1","article-title":"Ageing and infection","volume":"2","author":"G Gavazzi","year":"2002","journal-title":"Lancet Infect Dis"},{"issue":"01","key":"ref4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12890-018-0638-0","article-title":"Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis","volume":"18","author":"R Chandrasekaran","year":"2018","journal-title":"BMC Pulm Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2016.05.001","article-title":"Non CF-bronchiectasis: aetiologic approach, clinical, radiological, microbiological and functional profile in 277 patients","volume":"116","author":"K Dimakou","year":"2016","journal-title":"Respir Med"},{"issue":"08","key":"ref6","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.rmed.2007.03.009","article-title":"Microbiologic follow-up study in adult bronchiectasis","volume":"101","author":"P T King","year":"2007","journal-title":"Respir Med"},{"issue":"02","key":"ref7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/ppul.21331","article-title":"Do New Zealand children with non-cystic fibrosis bronchiectasis show disease progression?","volume":"46","author":"K A Munro","year":"2011","journal-title":"Pediatr Pulmonol"},{"issue":"06","key":"ref8","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.rmed.2014.07.021","article-title":"Non cystic fibrosis bronchiectasis: a longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance","volume":"109","author":"M J McDonnell","year":"2015","journal-title":"Respir Med"},{"issue":"08","key":"ref9","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1183\/09031936.96.09081601","article-title":"Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa","volume":"9","author":"S A Evans","year":"1996","journal-title":"Eur Respir J"},{"issue":"05","key":"ref10","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1183\/09031936.06.00074605","article-title":"The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis","volume":"28","author":"G Davies","year":"2006","journal-title":"Eur Respir J"},{"issue":"05","key":"ref11","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1378\/chest.07-0490","article-title":"Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis","volume":"132","author":"M A Mart\u00ednez-Garc\u00eda","year":"2007","journal-title":"Chest"},{"issue":"04","key":"ref12","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1378\/chest.108.4.955","article-title":"Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort","volume":"108","author":"M B Nicotra","year":"1995","journal-title":"Chest"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1164\/ajrccm.162.4.9906120","article-title":"An investigation into causative factors in patients with bronchiectasis","volume":"162","author":"M C Pasteur","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"01","key":"ref14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/thorax.57.1.15","article-title":"Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors","volume":"57","author":"J Angrill","year":"2002","journal-title":"Thorax"},{"issue":"10","key":"ref15","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1164\/rccm.201210-1937OC","article-title":"Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation","volume":"187","author":"M M Tunney","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"08","key":"ref16","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.3390\/jcm9082631","article-title":"Systemic inflammation during and after bronchiectasis exacerbations: impact of Pseudomonas aeruginosa","volume":"9","author":"R Men\u00e9ndez","year":"2020","journal-title":"J Clin Med"},{"issue":"04","key":"ref17","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1183\/13993003.01899-2015","article-title":"Clinical phenotypes in adult patients with bronchiectasis","volume":"47","author":"S Aliberti","year":"2016","journal-title":"Eur Respir J"},{"issue":"09","key":"ref18","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1513\/AnnalsATS.201510-678OC","article-title":"The multiple faces of non-cystic fibrosis bronchiectasis a cluster analysis approach","volume":"13","author":"M A Mart\u00ednez-Garc\u00eda","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"04","key":"ref19","first-page":"559","article-title":"Pseudomonas aeruginosa infection in cystic fibrosis. Distribution of B and T lymphocytes in relation to the humoral immune response","volume":"82","author":"N H\u00f8iby","year":"1974","journal-title":"Acta Pathol Microbiol Scand B Microbiol Immunol"},{"issue":"262","key":"ref20","first-page":"1","article-title":"Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey","author":"N Hoiby","year":"1977","journal-title":"Acta Pathol Microbiol Scand Suppl"},{"issue":"03","key":"ref21","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/thx.52.3.260","article-title":"Effects of airway infection by Pseudomonas aeruginosa: a computed tomographic study","volume":"52","author":"K A Miszkiel","year":"1997","journal-title":"Thorax"},{"issue":"08","key":"ref22","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1183\/09031936.97.10081754","article-title":"Effect of sputum bacteriology on the quality of life of patients with bronchiectasis","volume":"10","author":"C B Wilson","year":"1997","journal-title":"Eur Respir J"},{"issue":"03","key":"ref23","doi-asserted-by":"crossref","first-page":"1700629","DOI":"10.1183\/13993003.00629-2017","article-title":"European Respiratory Society guidelines for the management of adult bronchiectasis","volume":"50","author":"E Polverino","year":"2017","journal-title":"Eur Respir J"},{"issue":"11","key":"ref24","first-page":"1602","article-title":"A comprehensive analysis of the impact of Pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis","volume":"12","author":"S Finch","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"01","key":"ref25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1471-2466-14-103","article-title":"Pseudomonas aeruginosa isolates in severe chronic obstructive pulmonary disease: characterization and risk factors","volume":"14","author":"M Gallego","year":"2014","journal-title":"BMC Pulm Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2017.05.001","article-title":"Anti-Pseudomonas aeruginosa IgG antibodies and chronic airway infection in bronchiectasis","volume":"128","author":"G Suarez-Cuartin","year":"2017","journal-title":"Respir Med"},{"issue":"11","key":"ref27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3390\/jcm7110429","article-title":"Characterization of microbiota in bronchiectasis patients with different disease severities","volume":"7","author":"S H Lee","year":"2018","journal-title":"J Clin Med"},{"issue":"01","key":"ref28","doi-asserted-by":"crossref","first-page":"6871","DOI":"10.1038\/s41598-019-42862-y","article-title":"A longitudinal characterization of the non-cystic fibrosis bronchiectasis airway microbiome","volume":"9","author":"T E Woo","year":"2019","journal-title":"Sci Rep"},{"issue":"12","key":"ref29","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S2213-2600(14)70213-9","article-title":"The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial","volume":"2","author":"G B Rogers","year":"2014","journal-title":"Lancet Respir Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jcf.2005.05.018","article-title":"Eradication of early Pseudomonas aeruginosa infection","volume":"4","author":"N H\u00f8iby","year":"2005","journal-title":"J Cyst Fibros"},{"issue":"04","key":"ref31","doi-asserted-by":"crossref","first-page":"2000512","DOI":"10.1183\/13993003.00512-2020","article-title":"Omics-based tracking of Pseudomonas aeruginosa persistence in \u201ceradicated\u201d CF patients","volume":"57","author":"J A Bartell","year":"2021","journal-title":"Eur Respir J"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","article-title":"Bacterial biofilms: a common cause of persistent infections","volume":"284","author":"J W Costerton","year":"1999","journal-title":"Science"},{"issue":"05","key":"ref33","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1183\/09031936.06.00100805","article-title":"Evaluating the \u201cLeeds criteria\u201d for Pseudomonas aeruginosa infection in a cystic fibrosis centre","volume":"27","author":"M Proesmans","year":"2006","journal-title":"Eur Respir J"},{"issue":"11","key":"ref34","doi-asserted-by":"crossref","first-page":"e0208013","DOI":"10.1371\/journal.pone.0208013","article-title":"Adaptation of Pseudomonas aeruginosa to the chronic phenotype by mutations in the algTmucABD operon in isolates from Brazilian cystic fibrosis patients","volume":"13","author":"N Candido Ca\u00e7ador","year":"2018","journal-title":"PLoS One"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1146\/annurev.micro.56.012302.160705","article-title":"Biofilms as complex differentiated communities","volume":"56","author":"P Stoodley","year":"2002","journal-title":"Annu Rev Microbiol"},{"issue":"01","key":"ref36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrmicro1557","article-title":"Persister cells, dormancy and infectious disease","volume":"5","author":"K Lewis","year":"2007","journal-title":"Nat Rev Microbiol"},{"issue":"S 01","key":"ref37","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.cmi.2014.10.024","article-title":"ESCMID guideline for the diagnosis and treatment of biofilm infections 2014","volume":"21","author":"N H\u00f8iby","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"03","key":"ref38","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/ppul.23031","article-title":"Detection of biofilm in bronchoalveolar lavage from children with non-cystic fibrosis bronchiectasis","volume":"50","author":"R L Marsh","year":"2015","journal-title":"Pediatr Pulmonol"},{"issue":"12","key":"ref39","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nrmicro2907","article-title":"Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective","volume":"10","author":"A Folkesson","year":"2012","journal-title":"Nat Rev Microbiol"},{"issue":"03","key":"ref40","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cmi.2020.04.007","article-title":"Pseudomonas aeruginosa and lung function decline in patients with bronchiectasis","volume":"27","author":"M A Martinez-Garc\u00eda","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"06","key":"ref41","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/resp.12768","article-title":"Factors associated with radiologic progression of non-cystic fibrosis bronchiectasis during long-term follow-up","volume":"21","author":"J Park","year":"2016","journal-title":"Respirology"},{"issue":"07","key":"ref42","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1164\/rccm.201203-0487OC","article-title":"Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis","volume":"186","author":"J D Chalmers","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"02","key":"ref43","doi-asserted-by":"crossref","first-page":"1701953","DOI":"10.1183\/13993003.01953-2017","article-title":"The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis","volume":"51","author":"D Ara\u00fajo","year":"2018","journal-title":"Eur Respir J"},{"issue":"03","key":"ref44","doi-asserted-by":"crossref","first-page":"e014613","DOI":"10.1136\/bmjopen-2016-014613","article-title":"Pseudomonas aeruginosa isolation in patients with non-cystic fibrosis bronchiectasis: a retrospective study","volume":"8","author":"H Wang","year":"2018","journal-title":"BMJ Open"},{"issue":"04","key":"ref45","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/1479972316643698","article-title":"Annual direct medical costs of bronchiectasis treatment: impact of severity, exacerbations, chronic bronchial colonization and chronic obstructive pulmonary disease coexistence","volume":"13","author":"D de la Rosa","year":"2016","journal-title":"Chron Respir Dis"},{"issue":"12","key":"ref46","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.3390\/jcm9123800","article-title":"Impact of Pseudomonas aeruginosa infection on patients with chronic inflammatory airway diseases","volume":"9","author":"M Garcia-Clemente","year":"2020","journal-title":"J Clin Med"},{"issue":"05","key":"ref47","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","article-title":"The bronchiectasis severity index: an international derivation and validation study","volume":"189","author":"J D Chalmers","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"05","key":"ref48","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1183\/09031936.00026313","article-title":"Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score","volume":"43","author":"M A Mart\u00ednez-Garc\u00eda","year":"2014","journal-title":"Eur Respir J"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.rmed.2019.06.012","article-title":"Mucoid Pseudomonas aeruginosa alters sputum viscoelasticity in patients with non-cystic fibrosis bronchiectasis","volume":"154","author":"V Alcaraz-Serrano","year":"2019","journal-title":"Respir Med"},{"issue":"06","key":"ref50","first-page":"339","article-title":"Microscopic and baceriologic analysis of expectorated sputum","volume":"50","author":"P R Murray","year":"1975","journal-title":"Mayo Clin Proc"},{"issue":"02","key":"ref51","doi-asserted-by":"crossref","first-page":"161.e1","DOI":"10.1016\/j.cmi.2015.10.009","article-title":"Automated categorization of methicillin-resistant Staphylococcus aureus clinical isolates into different clonal complexes by MALDI-TOF mass spectrometry","volume":"22","author":"M Camoez","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.micro.57.030502.090720","article-title":"Bacterial biofilms: an emerging link to disease pathogenesis","volume":"57","author":"M R Parsek","year":"2003","journal-title":"Annu Rev Microbiol"},{"issue":"02","key":"ref53","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1574-695X.2012.00968.x","article-title":"Towards diagnostic guidelines for biofilm-associated infections","volume":"65","author":"L Hall-Stoodley","year":"2012","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"07","key":"ref54","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJMoa061588","article-title":"Sonication of removed hip and knee prostheses for diagnosis of infection","volume":"357","author":"A Trampuz","year":"2007","journal-title":"N Engl J Med"},{"issue":"02","key":"ref55","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jcf.2016.08.005","article-title":"Phenotypic shift in Pseudomonas aeruginosa populations from cystic fibrosis lungs after 2-week antipseudomonal treatment","volume":"16","author":"L Fern\u00e1ndez-Barat","year":"2017","journal-title":"J Cyst Fibros"},{"issue":"07","key":"ref56","doi-asserted-by":"crossref","first-page":"e00343-20","DOI":"10.1128\/JCM.00343-20","article-title":"Evaluation of the BioFire FilmArray Pneumonia Panel for detection of viral and bacterial pathogens in lower respiratory tract specimens in the setting of a tertiary care academic medical center","volume":"58","author":"D M Webber","year":"2020","journal-title":"J Clin Microbiol"},{"issue":"01","key":"ref57","doi-asserted-by":"crossref","first-page":"a560","DOI":"10.1093\/ofid\/ofaa560","article-title":"Performance of a semiquantitative multiplex bacterial and viral PCR panel compared with standard microbiological laboratory results: 396 patients studied with the BioFire Pneumonia Panel","volume":"8","author":"K H Rand","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"07","key":"ref58","doi-asserted-by":"crossref","first-page":"e00128-20","DOI":"10.1128\/JCM.00128-20","article-title":"Multicenter evaluation of the BioFire FilmArray Pneumonia\/Pneumonia Plus Panel for detection and quantification of agents of lower respiratory tract infection","volume":"58","author":"C N Murphy","year":"2020","journal-title":"J Clin Microbiol"},{"issue":"07","key":"ref59","doi-asserted-by":"crossref","first-page":"e00135-20","DOI":"10.1128\/JCM.00135-20","article-title":"Practical comparison of the BioFire FilmArray pneumonia panel to routine diagnostic methods and potential impact on antimicrobial stewardship in adult hospitalized patients with lower respiratory tract infections","volume":"58","author":"B W Buchan","year":"2020","journal-title":"J Clin Microbiol"},{"issue":"S 02","key":"ref60","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"L A Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"11","key":"ref61","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/thoraxjnl-2011-200206","article-title":"Immunity and bacterial colonisation in bronchiectasis","volume":"67","author":"D Whitters","year":"2012","journal-title":"Thorax"},{"issue":"01","key":"ref62","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3390\/pathogens4010066","article-title":"Bacterial adaptation during chronic respiratory infections","volume":"4","author":"L Cullen","year":"2015","journal-title":"Pathogens"},{"issue":"01","key":"ref63","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.molimm.2012.09.011","article-title":"Mechanisms of immune dysfunction and bacterial persistence in non-cystic fibrosis bronchiectasis","volume":"55","author":"J D Chalmers","year":"2013","journal-title":"Mol Immunol"},{"issue":"S 01","key":"ref64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/thoraxjnl-2018-212463","article-title":"British thoracic society guideline for bronchiectasis in adults","volume":"74","author":"A T Hill","year":"2019","journal-title":"Thorax"},{"issue":"04","key":"ref65","doi-asserted-by":"crossref","first-page":"1600851","DOI":"10.1183\/13993003.00851-2016","article-title":"Efficacy of Pseudomonas aeruginosa eradication regimens in bronchiectasis","volume":"49","author":"E Valli\u00e8res","year":"2017","journal-title":"Eur Respir J"},{"issue":"04","key":"ref66","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000438490","article-title":"Eradication therapy against Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis","volume":"90","author":"R Orriols","year":"2015","journal-title":"Respiration"},{"issue":"11","key":"ref67","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/resp.13398","article-title":"Bronchiectasis: treatment decisions for pulmonary exacerbations and their prevention","volume":"23","author":"S C Bell","year":"2018","journal-title":"Respirology"},{"issue":"10","key":"ref68","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1164\/rccm.201605-1027OC","article-title":"Neutrophil elastase activity is associated with exacerbations and lung function decline in bronchiectasis","volume":"195","author":"J D Chalmers","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"03","key":"ref69","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/1479972308091823","article-title":"Quality of life and inflammation in exacerbations of bronchiectasis","volume":"5","author":"J M Courtney","year":"2008","journal-title":"Chron Respir Dis"},{"issue":"08","key":"ref70","doi-asserted-by":"crossref","first-page":"e0133695","DOI":"10.1371\/journal.pone.0133695","article-title":"Increased peripheral blood pro-inflammatory\/cytotoxic lymphocytes in children with bronchiectasis","volume":"10","author":"G Hodge","year":"2015","journal-title":"PLoS One"},{"issue":"03","key":"ref71","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/ppul.21550","article-title":"Lower airway microbiology and cellularity in children with newly diagnosed non-CF bronchiectasis","volume":"47","author":"N Kapur","year":"2012","journal-title":"Pediatr Pulmonol"},{"issue":"01","key":"ref72","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/thoraxjnl-2014-205918","article-title":"Quality of Life Questionnaire-Bronchiectasis: final psychometric analyses and determination of minimal important difference scores","volume":"70","author":"A L Quittner","year":"2015","journal-title":"Thorax"},{"issue":"06","key":"ref73","doi-asserted-by":"crossref","first-page":"1700051","DOI":"10.1183\/13993003.00051-2017","article-title":"Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research","volume":"49","author":"A T Hill","year":"2017","journal-title":"Eur Respir J"},{"issue":"02","key":"ref74","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.arbres.2017.07.016","article-title":"Normativa sobre el tratamiento de las bronquiectasias en el adulto","volume":"54","author":"M\u00c1 Mart\u00ednez-Garc\u00eda","year":"2018","journal-title":"Arch Bronconeumol"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.rmed.2016.06.007","article-title":"Challenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis","volume":"117","author":"R Wilson","year":"2016","journal-title":"Respir Med"},{"issue":"12","key":"ref76","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.rmed.2006.03.012","article-title":"Characterisation of the onset and presenting clinical features of adult bronchiectasis","volume":"100","author":"P T King","year":"2006","journal-title":"Respir Med"},{"issue":"04","key":"ref77","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.chest.2020.06.050","article-title":"Airway clearance techniques in bronchiectasis: analysis from the United States Bronchiectasis and Non-TB Mycobacteria Research Registry","volume":"158","author":"A Basavaraj","year":"2020","journal-title":"Chest"},{"issue":"11","key":"ref78","first-page":"CD008351","article-title":"Airway clearance techniques for bronchiectasis","volume":"2015","author":"A L Lee","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"ref79","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/resp.13578","article-title":"Pseudomonas aeruginosa cross-infection: Is this important in bronchiectasis and COPD?","volume":"24","author":"P T King","year":"2019","journal-title":"Respirology"},{"issue":"S 61","key":"ref80","first-page":"PA4071","article-title":"Chest physiotherapy in European patients with bronchiectasis: data from the EMBARC registry","volume":"50","author":"B Herrero Cortina","year":"2017","journal-title":"Eur Respir J"},{"issue":"06","key":"ref81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/13993003.02138-2019","article-title":"Association between physical activity and risk of hospitalisation in bronchiectasis","volume":"55","author":"V Alcaraz-Serrano","year":"2020","journal-title":"Eur Respir J"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"102995","DOI":"10.1016\/j.ebiom.2020.102995","article-title":"Reconsidering ventilator-associated pneumonia from a new dimension of the lung microbiome","volume":"60","author":"L Fern\u00e1ndez-Barat","year":"2020","journal-title":"EBioMedicine"},{"issue":"03","key":"ref83","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S2213-2600(14)70028-1","article-title":"Towards an ecology of the lung: new conceptual models of pulmonary microbiology and pneumonia pathogenesis","volume":"2","author":"R P Dickson","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"02","key":"ref84","doi-asserted-by":"crossref","first-page":"e0170622","DOI":"10.1371\/journal.pone.0170622","article-title":"Longitudinal assessment of sputum microbiome by sequencing of the 16S rRNA gene in non-cystic fibrosis bronchiectasis patients","volume":"12","author":"M J Cox","year":"2017","journal-title":"PLoS One"},{"issue":"04","key":"ref85","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1513\/AnnalsATS.201310-335OC","article-title":"A novel microbiota stratification system predicts future exacerbations in bronchiectasis","volume":"11","author":"G B Rogers","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"04","key":"ref86","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/thoraxjnl-2016-208775","article-title":"FUT2 genotype influences lung function, exacerbation frequency and airway microbiota in non-CF bronchiectasis","volume":"72","author":"S L Taylor","year":"2017","journal-title":"Thorax"},{"issue":"153","key":"ref87","doi-asserted-by":"crossref","first-page":"190048","DOI":"10.1183\/16000617.0048-2019","article-title":"The microbiome in bronchiectasis","volume":"28","author":"H Richardson","year":"2019","journal-title":"Eur Respir Rev"},{"issue":"06","key":"ref88","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.2041-1014.2011.00622.x","article-title":"Community-based interference against integration of Pseudomonas aeruginosa into human salivary microbial biofilm","volume":"26","author":"X He","year":"2011","journal-title":"Mol Oral Microbiol"},{"issue":"02","key":"ref89","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/crj.13279","article-title":"Airway microbiota is associated with the severity of non-CF bronchiectasis","volume":"15","author":"L Li","year":"2021","journal-title":"Clin Respir J"},{"issue":"06","key":"ref90","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1165\/rcmb.2006-0035SF","article-title":"Regulation of mucin genes in chronic inflammatory airway diseases","volume":"34","author":"J A Voynow","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"05","key":"ref91","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1165\/rcmb.2005-0436SF","article-title":"Airway mucus: from production to secretion","volume":"34","author":"O W Williams","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"02","key":"ref92","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.addr.2008.09.012","article-title":"Micro- and macrorheology of mucus","volume":"61","author":"S K Lai","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"issue":"23","key":"ref93","doi-asserted-by":"crossref","first-page":"13549","DOI":"10.1021\/la802442d","article-title":"Microrheology of bacterial biofilms in vitro: Staphylococcus aureus and Pseudomonas aeruginosa","volume":"24","author":"S S Rogers","year":"2008","journal-title":"Langmuir"},{"issue":"01","key":"ref94","doi-asserted-by":"crossref","first-page":"9691","DOI":"10.1038\/s41598-018-28009-5","article-title":"Viscoelastic properties of Pseudomonas aeruginosa variant biofilms","volume":"8","author":"E S Gloag","year":"2018","journal-title":"Sci Rep"},{"issue":"01","key":"ref95","doi-asserted-by":"crossref","first-page":"16502","DOI":"10.1038\/s41598-020-73459-5","article-title":"Micro-rheological properties of lung homogenates correlate with infection severity in a mouse model of Pseudomonas aeruginosa lung infection","volume":"10","author":"X Murgia","year":"2020","journal-title":"Sci Rep"}],"container-title":["Seminars in Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1730921.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T22:47:03Z","timestamp":1626302823000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0041-1730921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,14]]},"references-count":95,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2021,7,14]]},"published-print":{"date-parts":[[2021,8]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1730921","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1069-3424","1098-9048"],"issn-type":[{"value":"1069-3424","type":"print"},{"value":"1098-9048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,14]]}}}